Zhejiang Jolly Pharmaceutical Co., Ltd. (300181) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Zhejiang Jolly Pharmaceutical Co., Ltd.

Why is Zhejiang Jolly Pharmaceutical Co., Ltd. ?

Positive results in Mar 26

OPERATING CASH FLOW(Y) Highest at CNY 572.84 MM
RAW MATERIAL COST(Y) Fallen by -6.47% (YoY)
NET SALES(Q) Highest at CNY 897.8 MM

With ROE of 19.30%, it has a attractive valuation with a 2.76 Price to Book Value

Over the past year, while the stock has generated a return of -18.89%, its profits have risen by 19.1% ; the PEG ratio of the company is 0.8
At the current price, the company has a high dividend yield of 2.6

Below par performance in long term as well as near term

Along with generating -18.89% returns in the last 1 year, the stock has also underperformed China Shanghai Composite in the last 3 years, 1 year and 3 months

Real-Time Research Report

Verdict Report

How much should you hold?

Overall Portfolio exposure to Zhejiang Jolly Pharmaceutical Co., Ltd. should be less than 10%
Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Zhejiang Jolly Pharmaceutical Co., Ltd. for you?

Medium Risk, Low Return

Absolute

Risk Adjusted

Volatility

Zhejiang Jolly Pharmaceutical Co., Ltd.

-21.75%

-0.44

29.54%

China Shanghai Composite

21.43%

1.55

13.83%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

20.33%

EBIT Growth (5y)

41.39%

EBIT to Interest (avg)

33.25

Debt to EBITDA (avg)

Net Debt is too low

Net Debt to Equity (avg)

-0.05

Sales to Capital Employed (avg)

0.74

Tax Ratio

13.81%

Dividend Payout Ratio

38.04%

Pledged Shares

Institutional Holding

ROCE (avg)

14.41%

ROE (avg)

12.89%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

2.76

EV to EBIT

13.90

EV to EBITDA

12.72

EV to Capital Employed

2.72

EV to Sales

3.07

PEG Ratio

0.75

Dividend Yield

2.59%

ROCE (Latest)

19.55%

ROE (Latest)

19.30%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

Mildly Bearish

RSI

No Signal

Bollinger Bands

Mildly Bearish

Bearish

Moving Averages

Bearish (Daily)

KST

Bearish

Mildly Bearish

Dow Theory

Mildly Bearish

OBV

Mildly Bullish

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

12What is working for the Company

OPERATING CASH FLOW(Y)

Highest at CNY 572.84 MM

RAW MATERIAL COST(Y)

Fallen by -6.47% (YoY

NET SALES(Q)

Highest at CNY 897.8 MM

PRE-TAX PROFIT(Q)

Highest at CNY 237.8 MM

NET PROFIT(Q)

Highest at CNY 199.59 MM

EPS(Q)

Highest at CNY 0.29

-10What is not working for the Company

DEBTORS TURNOVER RATIO(HY)

Lowest at 2.55 times

INTEREST(Q)

Highest at CNY 4.13 MM

Here's what is working for Zhejiang Jolly Pharmaceutical Co., Ltd.

Operating Cash Flow

Highest at CNY 572.84 MM

in the last three years

MOJO Watch

The company has generated higher cash revenues from business operations

Operating Cash Flows (CNY MM)

Net Sales

Highest at CNY 897.8 MM

in the last five periods

MOJO Watch

Near term sales trend is positive

Net Sales (CNY MM)

Net Sales

At CNY 897.8 MM has Grown at 18.35%

over average net sales of the previous four periods of CNY 758.61 MM

MOJO Watch

Near term sales trend is positive

Net Sales (CNY MM)

Pre-Tax Profit

Highest at CNY 237.8 MM

in the last five periods

MOJO Watch

Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (CNY MM)

Net Profit

Highest at CNY 199.59 MM

in the last five periods

MOJO Watch

Near term Net Profit trend is positive

Net Profit (CNY MM)

EPS

Highest at CNY 0.29

in the last five periods

MOJO Watch

Increasing profitability; company has created higher earnings for shareholders

EPS (CNY)

Raw Material Cost

Fallen by -6.47% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Zhejiang Jolly Pharmaceutical Co., Ltd.

Interest

Highest at CNY 4.13 MM

in the last five periods and Increased by 8.15% (QoQ)

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Debtors Turnover Ratio

Lowest at 2.55 times

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling Debtors has slowed

Debtors Turnover Ratio